Hemodynamic Monitoring Devices Market To Make Great Impact In Near Future by 2024| Key Industry Participants Hemo Sapiens, Inc

The global hemodynamic monitoring devices market is expected to reach USD 1.4 billion by 2024, according to a new report by Grand View Research, Inc. The increasing demand for non-invasive monitoring techniques coupled with the rising prevalence of chronic illness is expected to drive the market over the forecast period. 

The hemodynamic monitoring market is influenced by new technologies such as echocardiography, thoracic electrical bio-impedance and others that maybe used to non-invasively monitor parameters such as cardiac output, arterial pressure, blood oxygen level, and central venous pressure. 

Furthermore, the rising population of critically ill patients coupled with defective healthcare facilities with drawbacks, such as understaffing, is propelling market players to develop minimal invasive hemodynamic monitoring devices that may be used in clinical and home care settings. Along with the new product development, the market is also anticipated to witness the development of technologies that help in the early diagnosis of shock and sepsis. 

Furthermore, efforts by key industry players to understand critical illnesses at molecular levels leading to the development of efficient assessment products are expected to be witnessed over the forecast period. Hence, all these company strategies and the research conducted are eventually expected to promote market growth over the forecast period.

Access Research Report of Hemodynamic Monitoring Devices Market @ www.grandviewresearch.com/industry-analysis/hemodynamic-monitoring-devices-market

Further key findings from the study suggest:

• The disposables segment is anticipated to be the largest segment by 2024. The rising sale of hemodynamic monitoring systems and increasing applications of these systems in home care settings, hospitals, and clinics are expected to boost the segment growth.
• The non-invasive devices segment is expected to be the fastest growing hemodynamic monitoring market. Risks that include the development of arrhythmias due to the use of pulmonary artery catheter and the development of other methodologies that measure the cardiac output, such as echocardiographs, are the vital impact rendering drivers.
• Asia Pacific is anticipated to be the fastest growing regions and is anticipated to contribute to about 20.0% of the global revenue by 2024. The strengthening of the distribution channels by companies and the registration of products in countries, such as China, India, Australia, and others, are expected to support the growth over the forecast period. For instance, LiDCO Group, in their 2016 prelim report emphasized on its strategy of appointing new distributors for the Australian and South East Asian region.
• Major industry players are Edward Lifesciences, LiDCO Group Plc, Deltex Medical, Philips Medical, GE Healthcare, Noninvasive Medical Technologies, Inc., Tensys Medical, Inc., Cardio-Dynamics International, and Drager Medical, Inc. As mentioned above, the new product development is expected to drive the market over the forecast period.
• For instance, in March 2016, the LiDCO Group received the U.S. FDA approval for the LiDCO unity and launched the product in the European region. Along the same time, LiDCO also succeeded in registering itself in China to explore untapped territories and increase their global presence.

Grand View Research has segmented the Hemodynamic Monitoring Devices Market on the basis of product, type, end-use and regions. 

Global Hemodynamic Monitoring Devices Product Outlook (Revenue, USD Million, 2014 - 2024)

• Monitoring systems
• Disposables
• Services

Global Hemodynamic Monitoring Devices Type Outlook (Revenue, USD Million, 2014 - 2024)

• Invasive Hemodynamic Monitoring System
• Minimally Invasive Hemodynamic Monitoring System
• Non-invasive Hemodynamic Monitoring System

Global Hemodynamic Monitoring Devices End-use Outlook (Revenue, USD Million, 2014 - 2024)

• Hospitals
• Catheterization Laboratories
• Others

Hemodynamic Monitoring Devices Market Regional Outlook (Revenue, USD Million, 2014 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Internet of Things in Healthcare Market is Growing at Significant Rate 2025

The global IoT in healthcare market size is projected to reach USD 534.3 billion by 2025 expanding at a CAGR 19.9% over the forecast period, according to a new report by Grand View Research, Inc. Rise in investments for the implementation of IoT solutions in healthcare sector is one of the key factors driving the market. Increasing penetration of connected devices in various healthcare institutes and adoption of IoT systems and software solutions in healthcare operational activities are also among the key factors augmenting the market growth.

Growing preference for real-time data monitoring among the healthcare practitioners to manage chronic diseases is expected to propel the demand for IoT network in healthcare institutions. Combinations of remote monitoring, mobile platforms, and analytics have cut the rate of readmissions of patients suffering from congestive heart failure, diabetes, and blood pressure. Furthermore, advancements in communication technologies, such as real-time data transmission, has positively impacted the patients in manage chronic diseases and medication dosage, which has further fostered the market growth.

For instance, connected wheelchairs allow people with disabilities to communicate health alerts to care teams and engage with care providers. Growing number of IoT platform installations for better and early diagnosis and disease tracking is also contributing to the market development. Furthermore, rising demand for digital technologies for managing diseases, such as insomnia, diabetes, autism, heart disease, and asthma, is also poised to spur the market growth.

Access Research Report of Internet of Things in Healthcare Market@ https://www.grandviewresearch.com/industry-analysis/internet-of-things-iot-healthcare-market

Further key findings from the study suggest:

• In 2018, services held the largest revenue share owing to the high demand for improved decision-making in real-time and uninterrupted data flow between devices and people to uplift the efficiency of medical systems
• Hospitals and clinics held the largest revenue share in 2018 due to increased investments by hospitals to encourage the usage of digital technologies
• North America is expected to be the largest market owing to growing adoption of healthcare IT solutions and availability of sophisticated infrastructure in the region
• Asia pacific expected to witness the fastest CAGR over the forecast period owing to growing investments by the pharmaceuticals & medical devices companies and increasing adoption of advanced technologies
• Key companies operating in this market include Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Biotronik, and Boston Scientific

Grand View Research has segmented the global IoT in healthcare market on the basis of component, connectivity technology, end use, application, and region:

IoT in Healthcare Component Outlook (Revenue, USD Million, 2014 - 2025)

• Medical Devices
  • Wearable External Devices
  • Implanted Medical Devices
  • Stationary Medical Devices
• System and Software
  • Remote Device Management
  • Network Bandwidth Management
  • Data Analytics
  • Application Security
  • Network Security
• Services
  • System Integration Services
  • Consulting, Training, and Education
  • Support and Maintenance Services

IoT in Healthcare Connectivity Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Wi-Fi
• Bluetooth Low Energy
• ZigBee
• Near Field Communication (NFC)
• Cellular
• Satellite

IoT in Healthcare End Use Outlook (Revenue, USD Million, 2014 - 2025)

• Clinical Research Organizations
• Hospitals and Clinics
• Research and Diagnostic Laboratories
• Others

IoT in Healthcare Application Outlook (Revenue, USD Million, 2014 - 2025)

• Telemedicine
• Medication Management
• Clinical Operations
• Inpatient Monitoring
• Connected Imaging
• Others

IoT in Healthcare Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Surface Marker Detection Market is Expected To Register A Significant Growth Over The Forecast Period

The Report Cell Surface Marker Detection Market Analysis By Product (Flow Cytometry, Hematology Analyzers, Reagents & Kits), By Application (Disease Diagnosis & Identification, Research & Drug Discovery) And Segment Forecasts To 2022

The global cell surface marker detection market is expected to reach USD 6.49 billion by 2022, according to a new report by Grand View Research, Inc. This growth in demand can be attributed to rise in incidence of oncology diseases and other cell-associated disorders. 

Rapid introduction of advancements and automations in clinical laboratories is a key factor affecting this industry. Incorporation of novel algorithms pertaining to diagnosis and prognosis of chronic disorders is expected to fuel demand of this market in the coming years.

Requirement of solutions for data handling and interpretation of clinical conditions based on obtained results are anticipated to enhance potential for R&D in this sector, consequently driving market growth over the forecast period. 

Access Research Report of Cell Surface Marker Detection Market @ https://www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market

Further key findings from the report suggest:

• Flow cytometry devices accounted for over 70% of the revenue generated in the industry for 2014. This large share can be attributed to the growing advancement in these instruments such as enhancement in efficiency and resolution of fluorescence-based cytometric detectors. Furthermore, presence of large product portfolio of different industry players operating in cytometry is responsible for large market share of this technique. 
• Disease diagnosis and identification accounted for over 50% of the revenue generated in the market for 2014. High incidence rate of cell-associated disorders and oncology diseases that need to be treated in order to curb the mortality rate are the major drivers for growth of this segment. 
• Determination of novel drug targets and development of biopharmaceuticals for prognosis of chronic diseases is anticipated to propel growth of research and drug discovery sub-segment in the coming years. With expected development of this segment, the sector will witness lucrative growth over the forecast period. 
• North America accounted for the largest share of this sector for 2014, as there are is significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for biopharmaceuticals is also anticipated to fuel regional growth. 
• North America dominated the industry in 2014, with revenue estimated at USD 999.0 million. Presence of sophisticated healthcare infrastructure and favorable government initiatives with respect to analytical techniques and their applications for disease diagnosis and drug development are some key factors likely to drive growth. 
• Asia Pacific is expected to witness lucrative growth from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R&D investment and growing medical expenditures in emerging economies of India and China 
• Key participants of the cell surface marker detection industry include Siemens Healthcare, Nihon Kohden Corporation, Sartorius, Janssen Diagnostics Inc., Grifols SA, Thermo Fisher Scientific, BioRad Laboratories Inc., and F. Hoffman La Roche Ltd. 
• These participants are involved in R&D for production of cell-specific antibodies and collaborations with smaller entities operating in the market as well as with academic research laboratories in order to maintain their market position and enter the untapped market regions 

Grand View Research has segmented cell surface marker detection market on the basis of product, application, and region:

Cell Surface Marker Detection Product Outlook (Market Revenue in USD Million, 2012 - 2022)

• Flow Cytometry
• Hematology Analyzers
• Reagents & Kits

Cell Surface Marker Detection Application Outlook (Market Revenue in USD Million, 2012 - 2022)

• Disease Diagnosis & Identification
• Research & Drug Discovery
• Others

Cell Surface Marker Detection Regional Outlook (Market Revenue in USD Million, 2012 - 2022)

• North America
• Europe
• Asia Pacific
• RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Neuroscience Market will be worth USD 30.80 Billion by 2020

Global neuroscience industry demand was worth USD 24.09 Billion in 2013 and is anticipated to reach above USD 30.80 billion by 2020. Rising investment in R&D resulting in the development of numerous products in the neuroinformatics coupled with adequate funding from the government are key factors that drive growth in this market.

Neuro-informatics involve designing and developing efficient tools and algorithms that can augment the performance of structural and functional mapping. Global Neuroscience market is expected to grow at CAGR of 2.9% over the next seven years.

Increasing occurrence of malicious disorders including Parkinsonism and Alzheimer’s disease together with other inherited CNS disorders has resulted in increased necessity for new improvements in neuroscience industry. The market is expected to experience growth over the forecast period on account of growing demand in laboratories and academic centers. The market players aim at introducing unique technologies with the ability to obtain insights to understand better the compound nervous functionalities and neural manipulations. Furthermore, increasing aggregate geriatric population every year is anticipated to drive significantly the demand owing to a growing need for better treatment and medication.

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/neuroscience-market

Rising demand for imaging machines & microscopic devices and intraneural imaging tools for visualization of intra-neural links is also foreseen to serve as a growth driver for this industry over the forecast period. In 2013, electrophysiology technology, whole brain imaging and neuro-microscopy equipment intended for neuroscience research collectively formed the chief revenue producing units owing to rapid advancements in these techniques that allow brain imaging with single cell resolution PET, MRI, and other advanced microscopes are expected to witness substantial growth due to expected developments in near future.

Neuro-cellular manipulation and neuro-proteomic analysis are estimated to record fastest growth rate of over 3.5% owing to improvements regarding disease etiology over the forecast period. Instrumentation of technology modules for Neuroscience market accounted for the largest share of the market in terms of revenue as a result of highly priced instruments used in neuro-analytical testing. Also, data analysis and software implements are predicted to observe a significant growth in the next seven years on account of efficient data tracking algorithms and methodologies.

In 2013, North America emerged as the largest regional market contributing to over 40.0% of the overall revenue owing to extensive ongoing research projects assisted by government universities. Furthermore, the surge in the incidence of CNS-related disorders in the regional population is expected to propel growth in the next seven years.

The Asia Pacific industry for neuroscience is estimated to grow at a CAGR of nearly 3.0% over the forecast period to reach a revenue over USD 8.00 billion by 2020. The increase in patient awareness coupled with the presence of unmet medical needs on nervous system syndromes is expected to drive market growth. In addition to increasing healthcare expenses in emerging markets of China and India are anticipated to propel growth in demand.

Key companies include Sutter Instrument Corporation, Trifoil Imaging Inc., Newport Corporation, Femtonics Ltd., Neurotar Ltd., Scientifica Ltd, Intan Technologies, AxionBiosystemsNeuralynxInc, Blackrock Microsystems LLC, Thomas Recording GmbH, LaVisionBiotec GmbH, PlexonInc, Mediso Medical Imaging Systems, NeuroNexus Technologies and Alpha Omega.

The market is characterized by intense competition on account of growing number of firms and extensive R&D. Companies in the market emphasize on new developments using advanced technology to differentiate and trace neural mechanisms.

Grand View Research has segmented neuroscience market on the basis of technology, technology components, and region:

Neuroscience Technology Outlook (Revenue, USD Million, 2012 - 2020)

• Whole Brain Imaging
  • Structural imaging
  • Functional imaging
• Neuro-microscopy Electrophysiology
  • Fluorescence neuromicroscopy
    • Confocal
    • Two-photon
    • Epifluorescent
    • TIRF
  • Electron neuromicroscopy
    • Scanning electron
    • Electron tomography
    • Transmission electron
  • Light neuromicroscopy
• Neuro-functional Analysis
• Neuro-proteomic analysis
• Neuro-cellular manipulation
• Neuro-biochemical assays
• Stereotaxic surgeries
  • Neural activity implants
  • Long-term access implants
  • Neurochemistry
• Animal behavior
  • Non-human primates
  • Rodent related
  • Optogenetics actuators
  • Optogenetics sensors
  • Drosophila related
  • elegansrelated

Neuroscience Technology Component Outlook (Revenue, USD Million, 2012 - 2020)

• Instrumentation
• Data analysis and services
• Consumables

Neuroscience Regional Outlook (Revenue in USD Million, 2012 - 2020 )

• North America
• Europe
• Asia Pacific
• RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

ECG Equipment Market to Mark a Highest CAGR of 5.9% Through 2022| Top Industry Leaders Schiller AG, Nihon Kohden

The global ECG equipment market is expected to reach USD 6.3 billion by 2022, according to a new report by Grand View Research Inc. The rising incidences of cardiovascular disorders and government initiatives to make people aware about health check-ups are expected to boost market growth. In addition, the change in the medical preference from acute intervention to preventive care is expected to increase the demand for more accurate and cost-effective methods for heart monitoring.

According to the WHO, in 2012, around 17.5 million people died due to cardiovascular diseases. This is due to the late diagnosis and absence of early symptoms as the patient fails to keep record of his vital signs.

Owing to the increasing incidences, government is undertaking various awareness programs. According to the American Heart Association (AHA), 56% women identified heart disease as a leading cause of death in 2012 as compared to 30% in 1997.

Access Research Report of ECG Equipment Market@ www.grandviewresearch.com/industry-analysis/ecg-equipment-market

Further key findings from the report suggest:

• ECG monitoring equipment has high future growth potential owing to changing trend towards preventive care and new product innovation with data integration. In February 2014, Medtronic launched its FDA approved Reveal LINQ. The upgraded version of Reveal XT offers patient heart monitoring for three years with 20% more data memory than its previous version.
• ECG stress testing systems is one of the dominating segments of the market. The growing need for flexible stress systems and comprehensive data management is driving the market for this segment. Quinton 9500 series from Cardiac Science portable system allows physicians to optimize the examination space and enables more data integrations.
• Holter monitoring systems is another segment, which is expected to gain significant market share over the forecast period due to the fact that the system assists in identifying arrhythmias that takes place during certain activities such as exercise, stress, bowel movements, sleep, eating, and stress
• 2M Engineering Ltd. launched the VitaMove 2S ExG movement and ECG-recorder, which is equipped with 3-lead ECG holter, that combines daily activities with heart rate events/trends, ECG, and derivatives such as Heart Rate Variability (HRV)
• North America dominated the market in 2014 and is expected to grow at a CAGR of 5.8% over the forecast period. With major industry players situated in North America, the innovations and upgrading rates are higher as compared to other regions. In August 2015, InfoBionic along with Safeguard Scientists raised USD 8 million to commercialize Mome Kardia. Mome Kardia is a remote patient monitoring system based on the cloud technology that could be worn around the neck.
• Asia Pacific is expected to witness substantial growth during the forecast period owing to the rising incidence rate of heart diseases and growing manufacturing outsourcing in the region
• According to the Government of India, the prevalence of heart failure in the nation due to hypertension, obesity, coronary heart disease, obesity, rheumatic heart disease, diabetes ranges from 1.3 to 4.6 million and an annual incidence rate of 491,600 to 1.8 million
• As per a report published by the Associated Chambers of Commerce and Industry of India (ASSOCHAM), people have adopted unhealthy lifestyles along with increasing stress levels, decreasing physical activity, tobacco smoking, and increasing consumption of saturated fats
• Industry players are constantly fueling the market with newer technologies or upgrading existing technology. In May 2015, CardioComm Solutions, Inc. launched HeartCheck PEN. This Bluetooth wireless connectivity pen could be connected for data acquisition with Android and Apple smartphones.
• Apart from technology innovations, many industry players are expanding their global presence by signing distribution agreements with domestic distributors. In October 2015, iNeedMD Holdings, Inc. signed a distribution agreement with Clifton Africa Ltd. This one-year distribution agreement is worth USD 1.5 million.
• Key players of the ECG equipment market include Medtronic, GE Healthcare, Philips Healthcare, Schiller AG, Nihon Kohden, CardioComm Solutions, Inc., and Johnson & Johnson.

Grand View Research has segmented the global ECG equipments market on the basis of product type and region:

ECG equipment type outlook (Revenue, USD Million, 2012 - 2022)

• ECG Monitoring Equipment
• Holter Monitoring Systems
• Event Monitoring Systems
• ECG Stress Testing Systems

ECG equipment regional outlook (Revenue, USD Million, 2012 - 2022)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
• RoW
  • Australia
  • Brazil

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Banking Outsourcing Market Expected To Propel Industry Growth By 2022

The global cell banking outsourcing market is expected to reach USD 9.87 billion by 2022, according to a new report by Grand View Research, Inc. Factors attributing towards this anticipated market size include growing demand for gene therapy, stem cell therapy, biopharmaceutical production that target on novel active sites.

Additionally, rise in prevalence of oncology associated diseases and other infectious chronic disorders are expected to promote cytological R&D in which cell banking plays a pivotal role thereby driving growth. R&D for commercialization of novel characterization and cryopreservation methods is also expected to considerably enhance lucrative growth opportunities over the forecast period.

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/cell-banking-outsourcing-market

Further key findings from the report suggest:

• Master cell banks accounted for over 60% of revenue generated in 2014 owing to rise in these facilities across the globe. Moreover, master cell banks are useful for the preparation of working cell banks and thus find applicability in various research and development perspectives for stem cell therapy and gene therapy thereby resulting to segment growth.
• Stem cells accounted for the largest share with respect to revenue in cell banking market by cell type. Factors attributive towards large share of this segment include availability of stem cells from different organ origins and there consequent use in different metabolic disorders.
• North America accounted for the largest share of this market for 2014, as there are a significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for vaccines and biopharmaceuticals is also anticipated to fuel the growth of this region.
• Asia Pacific is expected to witness significant growth in demand over the forecast period owing to increase in number of supportive government initiatives pertaining to investments in biotechnology sector. Additionally, ongoing R&D activities for cancer treatment and fertility preservation facilitate the demand for cell banking services.
• Key participants in the cell banking outsourcing market include BioReliance, BioOutsource (Sartorious), BSL Bioservice, Cleancells, Charles River Laboratories, Covance, GlobalStem Inc., Lonza, PX’Therapeutics SA, SGS Life Sciences, Texcell, Toxikon Corporation, Wuxi Apptec, Reliance Life Sciences, LifeCell International Pvt. Ltd., Cryobanks International India, Cryo-Cell International Inc., and CordLife.
• Market participants are involved in R&D for characterization of cell banks which include introduction of efficient gene sequencing tests, karyology, and safety tests.

Grand View Research has segmented cell banking outsourcing market on the basis of bank type, cell type, phase of development of cell bank, and region:

Cell Banking Outsourcing Outlook, by Bank Type (Revenue, USD Million, 2012 - 2022 )

• Master Cell Banking
• Working Cell Banking
• Viral Cell Banking

Cell Banking Outsourcing Outlook, by Cell Type (Revenue, USD Million, 2012 - 2022 )

• Stem Cell Banking
  • Cord Stem Cell Banking
  • Embryonic Stem Cell Banking
  • Adult Stem Cell Banking
  • Dental Stem Cell Banking
  • IPS Stem Cell Banking
• Non-stem Cell Banking

Cell Banking Outsourcing Phase Outlook (Revenue, USD Million, 2012 - 2022 )

• Cell Bank Storage
  • Master Cell Bank Storage
  • Working Cell Bank Storage
  • Cell Storage Stability Testing
• Bank Characterization and Testing
  • Safety Testing
    • Viral Cell Bank Safety Testing
    • Microbial Cell Bank Safety Testing
    • Gene Expression Testing
    • Karyology Testing
    • Gene Sequencing Testing
  • Cell Bank Preparation
    • Master Cell Bank Preparation
    • Working Cell Bank Preparation

Cell Banking Outsourcing Regional Outlook (Revenue, USD Million, 2012 – 2022)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK
• Asia Pacific
  • Japan
  • China
  • India
  • Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Blood Pressure Monitoring Device Market Expected to Succeed in CAGR of 10.1% by 2026

The global blood pressure (BP) monitoring devices market size is expected to reach USD 2.47 billion by 2026, according to a new report by Grand View Research, Inc. exhibiting a CAGR of 10.1% during the forecast period. The growing global geriatric population base is expected to widen the consumer base by triggering incidence rates of hypertension, which is expected to drive the demand for blood pressure monitoring devices. Increasing incidence of hypertension has led to rising demand for cost-effective, rapid and accurate diagnostic solutions. Blood pressure monitors are one of the vital sign monitors of life. The cost-effective and accurate results offer by these indicators is the factor responsible for the market growth.

In addition, new product launches coupled with rising adoption of technologically advanced products due to high penetration of health insurance is considered as another factor fueling the demand for BP monitoring devices. The increasing popularity of mHealth platform in the healthcare sector is additionally, propelling the market growth. Rising patient awareness levels about advantages associated with portable monitoring devices are expected to positively reinforce market growth.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-pressure-monitoring-devices-market

Further Key Findings From the Report Suggest:

• Sphygmomanometer/ aneroid BP monitors dominated the overall market in 2018 in terms of revenue share, owing to the increasing prevalence of high blood pressure worldwide.
• Ambulatory blood pressure monitoring device market is driven by factors such as increasing adoption by clinicians and awareness about it.
• Digital BP monitors segment is expected to witness lucrative growth in the coming years owing to advantages associated with these devices such as ease of use, immediate results, and low cost. In addition, continuous improvement in these devices is expected to present this market with further growth opportunities.
• Home healthcare segment is expected to witness lucrative growth owing to the government initiatives to promote home healthcare.
• In 2018, North America was the key regional market in terms of revenue share. Key factors attributing to its large share include the presence of advanced healthcare infrastructure and increasing prevalence of lifestyle-associated diseases with a high risk of hypertension.
• Higher awareness levels, increasing demand for early diagnostics & prevention and increasing stress levels leading towards high blood pressure are the factors responsible for the market growth.
• Asia Pacific blood pressure monitoring device market is expected to demonstrate rapid growth during the forecast period with CAGR of 12.2% key factors attributing to its rapid growth include favorable government initiatives such as the government of India's campaign "Make In India" which is intended to attract FDI and international players to invest in Indian market. In addition, rapidly improving healthcare facilities are anticipated to market growth.
• The key players operating in the market include Omron Healthcare, GE Healthcare, A&D Medical Inc., Welch Allyn Inc., SunTech Medical, Inc., Withings, Briggs Healthcare, Microlife AG, Kaz Inc., Philips Healthcare, American Diagnostics Corporation, Rossmax International Ltd., Spacelabs Healthcare Inc., and GF Health Products Inc.

Grand View Research has segmented the global blood pressure monitoring device market on the basis of product, end-use, and region:

Blood Pressure Monitoring Device Product Outlook (Revenue, USD Million; 2014 - 2026)

• Sphygmomanometer/Aneroid BP Monitor
• Automated/Digital Blood Pressure Monitor
  • Arm
  • Wrist
  • Finger
• Ambulatory Blood Pressure Monitor
• Transducers
  • Disposable
  • Reusable
• Instruments and Accessories
  • Blood pressure cuffs
    • Disposable
    • Reusable
  • Others

Blood Pressure Monitoring Devices End-Use Outlook (Revenue, USD Million; 2014 - 2026)

• Hospitals
• Ambulatory Surgical Centers & Clinics
• Home Healthcare

Blood Pressure Monitoring Devices Regional Outlook (Revenue, USD Million; 2014 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Urinary Catheters Market to Partake Significant Development During 2018 to 2024

The global urinary catheters market is expected to reach USD 5.51 billion by 2024, according to a new report by Grand View Research, Inc. The key contributors for the expansion of the market include the rising incidence of urinary disorders, growing elderly population, and technological advancements pertaining to the relevant devices.

These catheters have application in patients suffering from urinary retention, urinary incontinence, benign prostatic hyperplasia, and other disorders. Patients suffering from multiple sclerosis, spina bifida, cerebral palsy, spinal cord injuries, prostate enlargement, and cancer also require need them The WHO states that bladder problems affect more than 200 million people globally. Benign Prostate Hyperplasia (BPH) is most common in the ageing population, especially men, and urinary retention is a very common complication in BPH. Transurethral resection of the prostate is a common surgery for BPH and the Urology Care Foundation estimates that around 150,000 men in the U.S. undergo this surgery each year.

The technological development pertaining to these instruments are expected to drive the demand further. The catheters become infected after a couple of weeks and can cause infection of the tract. The development of new antimicrobial catheters with introduced antimicrobial molecules within the tube has advantage over the traditional ones.

Furthermore, the reimbursement policies for these products can also be attributed to the growing demand. The Medicaid program reimburses a patient with 120 intermittent catheters per month and the Medicare Program reimburses around 200 catheters per month.

Access Research Report of Urinary Catheters Market@ www.grandviewresearch.com/industry-analysis/urinary-catheters-market

Further Key Findings From the Study Suggest:

• In 2015, intermittent catheters was the dominant segment due to less chances of infections associated with their usage and thus being more preferred over the other two types
• In 2015, urinary incontinence was the largest application segment due to the rising prevalence of the disease with aging population.
• North America dominated the market in 2015. The U.S. is the largest market in North America owing to the high prevalence of urology disorders, rising geriatric population, and reimbursement policies.
• Asia Pacific is expected to be the fastest growing during the forecast period owing to the improving infrastructure in emerging economies and increasing interest of large players in this region
• The market dynamics indicate the presence of strong competition amongst the key players like Coloplast; Boston Scientific Corporation; Hollister, Inc.; B Braun Melsungen AG; Teleflex Inc.; Medtronic and many others.

Grand View Research has segmented the urinary catheters market by product, application, and region:

Urinary Catheters Product Type Outlook (Market revenue in USD Million, 2013 - 2024)

• Intermittent catheters
• Foley/ Indwelling catheters
• External catheters

Urinary Catheters Application Outlook (Market revenue in USD Million, 2013 - 2024)

• Benign prostate hyperplasia and prostate gland surgeries
• Urinary incontinence
• Spinal cord injury
• Others

Urinary Catheters Regional Outlook (Market revenue in USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Coagulation Analyzer Market to Grow at CAGR of 10.2% through 2024

The global coagulation analyzers/reagents market is expected to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years.

The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.

Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:

• Integration of the system with track line systems and work cells, which may improve the reliability of analysis in terms of single detection system and preanalytical check for interfering substances
• Failure pattern sensors, which detect insufficient sample levels and clots and cap piercing, which enhances safety and sample integrity
• Automatic reflex testing, repeat testing, and redilution

Access Research Report of Coagulation Analyzer Market@ www.grandviewresearch.com/industry-analysis/coagulation-analyzers-market

Further key findings from the study suggest:

• Clinical laboratory analyzers held over 70.0% of the market share in 2015 and are predicted to sustain its dominance over the forecast period.
• Advantages such as use of whole blood as sample, no pre-analytical delay and requirement of lesser reagents, further boost growth of Point of Care analyzers.
• Reagents held the highest market share in 2015. This dominance may be attributed to increasing usage of hemostasis analyzers coupled with easy availability of reagents.
• Optical technology based hemostasis analyzers held the largest share in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast period.
• The market is majorly dominated by the prothrombin test. The APTT test is estimated to account for the second largest share in the market in 2015.
• Hospitals are expected to witness lucrative growth over the forecast period. This can be attributed to high number of hospitals in developing economies.
• For instance, Mexico has over 4,500 hospitals and out of these 67.0% hospitals are private and remaining 33.0% hospitals are public hospitals.

Grand View Research has segmented the global Coagulation Analyzers & Reagents market on the basis of product, technology, test type, end-use and region.

Product Outlook (Revenue, USD Million, 2013 - 2024)

• Analyzers
  • Clinical Laboratory Analyzers
  • Point of Care Analyzers   
• Consumables
  • Reagents
  • Stains

Technology Outlook (Revenue, USD Million, 2013 - 2024)

• Mechanical
• Electrochemical
• Optical
  • Photo optical/Chromogenic/Immuno
  • Others/Nephelometric
• Others

Test Type Outlook (Revenue, USD Million, 2013 - 2024)

• APTT
• D-Dimer
• Fibrinogen
• Prothrombin
• Others

End-Use Outlook (Revenue, USD Million, 2013 - 2024)

• Hospitals
• Research Institutes
• Diagnostic Centers
• Others

Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Infection Control Market Expected to Witness a Sustainable Growth over 2025|Key participants STERUS Corporation, Cantel Medical Corporation

The global infection control market is expected to reach USD 258.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is driven by rising concerns with respect to a significant upsurge in hospital acquired infections globally. This is believed to facilitate greater penetration of infection control products. An influx in development of new biologics and subsequent demand for sterilized formulations serve as key growth factors for the overall infection control market.

The healthcare organizations are focused on implementing strategies for early recognition, reporting, isolation, and surveillance of disease episodes of potential public health concern. In addition, increasing number intensive training modules, for nurses and other medical staff, on infection prevention and control is presumed to provide high potential for extensive usage of infection control products over the coming years.

For instance, College of Nurses of Ontario released guidelines concerning standard practices, that is focused on maintaining hand hygiene to reduce contamination and spread of infection. Furthermore, Centers for Disease Control and Prevention (CDC) has released guidelines for disinfection and sterilization for efficient usage of infection control products by healthcare personnel in wide array of healthcare settings such as ambulatory care, home care, hospitals, and others. As a consequence of the aforementioned factors, it is presumed that there will be significant improvement in the overall penetration rate of infection prevention and control products, which is also anticipated to fuel the market demand as well as the revenue to unprecedented heights.

Access Research Report of Infection Control Market@ www.grandviewresearch.com/industry-analysis/infection-control-market

Further key findings from the report suggest:

• In the type segment, services are predicted to observe exponential growth as a consequence of increasing presence of third-party reprocessors and outsourcing of sterilization as a result of associated cost efficiency
• In the end-use segment, hospitals accounted for substantial share in 2016, as a consequence of high clinical urgency to curb the growing incidence of hospital acquired infections
• North America captured a dominant share of the overall infection control market owing to extensive infection prevention activities being implemented in hospitals, medical device and pharmaceutical companies
• The market in Asia Pacific is projected to witness exponential growth during the forecast period as a result of increasing awareness pertaining to spread of infections within healthcare settings and measures for prevention
• The competitive environment is marked by companies adopting sustainability strategies such as geographical expansion and mergers & acquisitions resulting in significant growth in their market share
• For instance, in July 2016, the Getinge Group acquired 1stCall Mobility Ltd, a company specializing in supplying rental equipment. This acquisition was carried out as a part of the company’s expansion strategy

Grand View Research has segmented the global infection control market on the basis of type, end use, and region:

Infection Control Type Outlook (Revenue, USD Billion, 2014 - 2025)

• Equipment
• Services
• Consumables

Infection Control End-use Outlook (Revenue, USD Billion, 2014 - 2025)

• Hospitals
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Companies
• Others

Infection Control Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Osteoporosis Drugs Market Revenue Sales to Reach USD 16.3 Billion by 2025

The global osteoporosis drugs market is expected to reach USD 16.3 billion by 2025, according to a new study by Grand View Research, Inc. An upsurge rise in the unhealthy lifestyle adoption has resulted in aggravation and increase in the prevalence of osteoporosis which is presumed to propel the osteoporosis drugs market during the forecast period.

In addition, growing number of patent expiries is fueling the high clinical urgency to use generic versions of the established drugs, which is presumed to fuel generic osteoporosis drugs market during the forecast period. The aforementioned factors cumulatively are slated to present the with high potential growth opportunities over the coming years.

Furthermore, rising number of initiatives to increase the awareness levels pertaining to osteoporosis care amongst the patients as well as the physicians is expected to widen the osteoporosis market growth potential during the forecast period. For instance, National Osteoporosis Foundation (NOF), a healthcare organization responsible for National Bone Health Alliance and Fracture Liaison Service (FLS) care coordination programs that focuses on elevating awareness levels as well as provides training to healthcare professionals

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/osteoporosis-drug-market

Further key findings from the study suggest:

• Branded drugs held the dominant share of the product segment in 2015. The dominant share can be attributed to extensive utilization of bisphosphates, rank ligand inhibitors for the treatment of osteoporosis, possessing high efficacy
• Generics are expected to witness at a lucrative CAGR owing to consistent patent expiries over the coming years as well as high clinical urgency for inexpensive medication in the emerging economies
• In 2015, North America accounted for the largest share in the global osteoporosis drugs market owing to the presence of established companies extensively involved in the commercialization of branded therapeutics
• Asia Pacific is anticipated to grow at an exponential CAGR as a consequence of favorable government initiatives promoting information pertaining to osteoporosis care
• The key participants are employing sustainability strategies promoting the adoption of osteoporosis therapeutics to gain competitive advantage. For instance, Actavis Inc. announced to acquire Warner Chilcott PLC in order to widen their product portfolio

Grand View Research has segmented the osteoporosis drugs market on the basis of product and region:

Global Osteoporosis Product Outlook (Revenue, USD Million, 2014 – 2025)

• Branded
  • Bisphosphonates
  • Parathyroid Hormone Therapy
  • Calcitonin
  • Selective Estrogen Inhibitors Modulator(SERM)
  • Rank Ligand Inhibitors
  • Others
• Generics

Osteoporosis Drugs Regional Outlook (Revenue, USD Billion, 2014 – 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

STD Diagnostics Market Significant Profits Estimated to be Generated by 2022

Global STD diagnostics market is expected to reach USD 200.9 billion by 2022 according to a new study by Grand View Research Inc. The rising geriatric population base, increasing global incidence of various STIs, rise in sedentary lifestyle adoption levels, and rising awareness & patient education are the driving forces for the STD diagnostics market growth over the forecast period. 

Increasing number of people having multiple partners and low levels of infection awareness levels are the major drivers fueling industrial growth. Increasing demand for rapid and accurate diagnostic tests and presence of favorable government initiatives for STD testing in developing countries such as Brazil, India, and China are further estimated to boost market growth. 

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/diagnostic-testing-of-stds-market

Further key findings from the study suggest:

• Chlamydia testing accounted for over 34% of the market in 2014. Chlamydia testing for sexually active women aged below 25 years is strictly recommended by the U.S Preventive Services Task Force (PSTF). Syphilis testing is estimated to witness lucrative growth over the forecast period. It is anticipated to grow at a CAGR of 10% owing to increasing prevalence of syphilis infection globally.
• On the basis of test location, laboratory testing held the largest market share of over 63% in 2014 owing to the availability of cost effective diagnostic tests used for multiple STIs at a single location such as public health labs. Point of care on the other hand is anticipated to be the fastest growing segment over the forecast period owing to the owing to the introduction of CLIA waived tests
• Laboratory testing devices dominated the market in 2014 with revenue generation of over 67.0 billion. Immunochromatographic assays were most preferred devices for STD diagnosis in laboratory with revenue share of over 26%. Increasing technological advancements are estimated to enhance usage rates of thermal cyclers over the forecast period.
• Portable/bench top or rapid diagnostic kits are estimated to gain demand over the forecast period owing to features such as user-friendliness, increasing awareness pertaining to self testing, and fast results.
• North America held the largest share of the STD diagnostics market with revenue generation of over 32 billion in 2014. Introduction of technologically advanced diagnostics techniques such as immunochromatographic device by Chembio Diagnostics Systems Inc. is the major factor attributing for its largest market share.
• Asia Pacific region is estimated to witness significant growth over the forecast period owing to the presence of high amount of target population, rising awareness levels for STIs, and increasing government initiatives and rise in disposable income expenditure levels. Asia Pacific is expected to show double digit CAGR growth over the forecast period.
• Major companies of the STD diagnostics industry include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, BioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure
• Licensing and partnership deal making activities in the molecular diagnostics sector are growing significantly in terms of value. New entrants such as life science research groups, financial investors, clinical laboratories, and medical technology players drive up the values. 

Grand View Research has segmented the global STD diagnostics market on the basis of product and region:

Global STD Diagnostics Type Outlook (Revenue, USD Billion, 2012 - 2022)

• Chlamydia testing
• Syphilis testing
• Gonorrhea testing
• Herpes Simplex Virus testing
• Human Papilloma Virus testing
• Human Immunodeficiency Virus testing
• Chancroid testing
• Others

Global STD Diagnostics Location of Testing Outlook (Revenue, USD Billion, 2012 - 2022)

• Laboratory Testing
  • Commercial/Private Labs
  • Public Health Labs
• Point of Care (PoC) testing

Global STD Diagnostics Testing Device Outlook (Revenue, USD Billion, 2012 - 2022)

• Laboratory Devices
  • Thermal Cyclers - PCR
  • Lateral Flow Readers – Immuno chromatographic assays
  • Flow Cytometers
  • Differential Light Scattering machines
  • Absorbance micro plate reader - Enzyme Linked Immunosorbent Assay (ELISA)
  • Others
• Point of Care (PoC) Devices
  • Phone chips (micro fluidics + ICT)
  • Portable/bench top/rapid diagnostic kits

STD Diagnostics Regional Outlook (Revenue, USD Billion, 2012 - 2022)

• North America
  • US.
  • Canada
• Europe
  • Sweden
  • Germany
• Asia Pacific
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Varicose Vein Treatment Market Set to Witness an Uptick by 2024|Top Industry Leaders Medtronic plc, Dornier MedTech GmbH

The Report Varicose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation (Laser Ablation, Radiofrequency Ablation), Stripping, And Segment Forecasts To 2024

The global varicose vein treatment market is expected to reach USD 475 million by 2024, according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market. 

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market. 

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.  

Access Research Report of Varicose Vein Treatment Market @ www.grandviewresearch.com/industry-analysis/varicose-vein-treatment-devices-market

Further key findings from the report suggest: 

• In 2015, the sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.
• The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segmenthas gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.
• In 2015, the endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.
• In 2016, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region
• As of 2016, Europe is characterized by a shift towards less-invasive procedures in treating large varicose veins. It is expected to witness a high growth rate over the forecast period due to the favorable government initiatives and advanced treatment procedures.
• The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income
• Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.
• AngioDynamics, Inc. and MerzPharma GmbH & Co. KGaAin North America established a multi-year relationship to market Asclera for patients with peripheral vascular diseases.In the U.S,.MerzPharma GmbH & Co. KGaAserves as the exclusive distributor of the Asclera Injection. Asclera is approved for the treatment of spider and reticular veins, which showed good improvement in 95% of the patients treated with asclera.
• In 2016, Medtronic plc acquired Italian hemodialysis player Bellco, Inc.This acquisition is projected to enable the medical device giant to gain market position in newly formed renal care solution business.
• In 2015, Medtronic plc acquired Covidien plc with the objective to move into the additional therapeutic areas, such as chronic venous insufficiency. Covidien plc markets the Venefit procedure that uses radiofrequency energy and minimally invasive radiofrequency ablation to treat the disease. 

Grand View Research has segmented the global varicose vein treatment market on the basis of procedures, devices,and regions: 

Varicose Vein Treatment Outlook ByType (Revenue, USD Million, 2013 - 2024)

• Sclerotherapy
• Endovenous Ablation
• Stripping

Varicose Vein Treatment Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Compressors Market Predicted to Cross USD 315.88 Million by 2020

Global Dental Compressors Market is expected to reach USD 315.88 Million by 2020, according to a new study by Grand View Research, Inc. Growing worldwide prevalence of dental disorders is expected to drive market growth during the forecast period. Introduction of new products based on oil free technology such as AirStar 12 and AirStar 40 which are maintenance free and provide ultra-dry and clean air are also expected to serve the dental compressors market as drivers. Furthermore, commercialization of membrane based compressors is expected to boost usage rates. Key advantages associated with these compressors include low installation and operating costs, no moving parts and their ability to function in hazardous atmospheres. Moreover, membrane based dryers not only supply hygienic, dry and oil free air but also minimize infection risks and increase treatment efficiency by reducing maintenance levels.

Desiccant based dental compressors were the leading product segment in 2013 owing to its characteristic of not reacting chemically with moisture. In most of the European countries, desiccant compressors are more reliable as the weather in the region can get as high as 30 degree Celsius or as low as 0 degree Celsius. The fact that these compressors exhibit optimum performance at these temperature ranges is expected to drive market growth. Desiccant based compressors are expected to grow at a CAGR over 3.0% during the forecast period.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/dental-compressors-market

Further key findings from the study suggest:

• The oil free compressors market is expected to grow at a CAGR of over 6.0% from 2014 to 2020. Key factors attributing to its fast growth includes their compact size and design enabling them to run smoothly with limited vibration and their ability to provide moisture oil and bacteria free dental air with very low maintenance cost.
• Dental compressors in handpieces accounted for over half of the market owing to rising prevalence of dental disorders, growing number of trained dental professional, rising patient awareness levels and increasing healthcare expenditure levels are few factors attributing to the growth of the dental care industry and the consequent rise in demand for dental compressors in handpieces.
• North America dominated the overall market in terms of market share in 2013 majorly on account of the presence of favorable reimbursement policies, economic development and increasing prevalence of dental disorders.
• The Asia Pacific dental compressors market is expected to grow at the fastest rate during the forecast period. Increasing geriatric population base, rising patient awareness levels and growing prevalence of target diseases are few factors attributing to its rapid growth.
• Key players operating in dental compressors include Midmark, Dürr Dental, Gnatus, Metasys, Tech West Inc, Kaeser Dental, Air Techniques, Aixin Medical Equipment Co., Ltd, Foshan Core Deep Medical Apparatus Co. Ltd, Best Dent Equipment Co., Limited, Slovadent, Dental EZ Group, Diplomat Dental Solutions and Fedesa.

For the purpose of this study, Grand View Research has segmented the global dental compressors market on the basis of product, technology, application and region:

Global Dental Compressors Product Outlook (Revenue, USD Million, 2012 – 2020)

• Dental lubricated compressors
• Dental oil-free compressors

Global Dental Compressors Technology Outlook (Revenue, USD Million, 2012 – 2020)

• Desiccant based compressors
• Membrane based compressors

Global Dental Compressors Application Outlook (Revenue, USD Million, 2012 – 2020)

• Handpieces
• Scalers
• Chair Valves

Dental compressors Regional Outlook (Revenue, USD Million, 2012 – 2020)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• MEA
  • Israel
  • South Africa
• Latin America
  • Brazil 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surgical Imaging Market Booming Trends and Forecast Assessment for the Period 2019 to 2026

The global surgical imaging market size is projected to reach USD 7.3 billion by 2026 expanding at a CAGR of 5.2%, according to a new report by Grand View Research, Inc. Technological advancements and growing demand for minimally invasive surgeries are the key factors augmenting the market growth. Surgical imaging can be used with different modalities, such as optical mode, ultrasound, radiography, and nuclear medicine. Rising scope of applications of imaging modules in a wide range of surgery procedures is expected to create significant opportunities.

Demand for surgical imaging systems is expected to show a steep growth due to high prevalence of chronic diseases including cancer and lifestyle disorders, and rising geriatric population, and demand for non-invasive and minimally invasive surgical methods. The endoscopy and laparoscopy devices are extensively used in minimally invasive surgeries. Key companies in the global market use different strategies to sustain the competition. For instance, in June 2017, Philips acquired Electrical Geodesics, Inc. to launch a portfolio with integrated neurological imaging, therapy, and mapping guidance.

Access Research Report of Surgical Imaging Market @ https://www.grandviewresearch.com/industry-analysis/surgical-imaging-market

Further key findings from the study suggest:

• The X-ray segment is expected to lead the market on account of increasing prevalence of chronic diseases and demand for surgical imaging procedures for better treatment
• The demand for mobile X-ray devices is expected to grow rapidly owing to rising geriatric population and need for bedside imaging
• Orthopedic and trauma is anticipated to be the largest and fastest-growing application segment over the forecast years
• C-arms is expected to be the fastest-growing device segment in the global surgical imaging market
• North America accounted for the largest share with U.S. capturing the largest share of the regional market in 2017
• Some of the key companies include Siemens Healthcare; Hitachi Ltd.; GE Healthcare; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Hologic, Inc.; Medtronic, PLC; and Shimadzu Corporation

Grand View Research has segmented the global surgical imaging market on the basis of device, modality, application, and region:

Surgical Imaging Device Outlook (Revenue, USD Million, 2014 - 2026)

• Endoscopy
• Laparoscopy
• Angiography
• C-arms
• Surgical Navigation Systems

Surgical Imaging Modality Outlook (Revenue, USD Million, 2014 - 2026)

• MRI
• X-ray
• Computed Tomography
• Optical
• Nuclear Imaging
• Ultrasound

Surgical Imaging Application Outlook (Revenue, USD Million, 2014 - 2026)

• Neurosurgeries
• Cardiovascular
• Orthopedic and Trauma
• Gynecological
• Ophthalmological
• Thoracic
• Urologic
• Other

Surgical Imaging Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.